sultamicillin and Brain-Abscess

sultamicillin has been researched along with Brain-Abscess* in 4 studies

Trials

1 trial(s) available for sultamicillin and Brain-Abscess

ArticleYear
Treatment of intracranial abscesses: experience with sulbactam/ampicillin.
    Journal of chemotherapy (Florence, Italy), 1993, Volume: 5, Issue:3

    In an open prospective study, the efficacy of sulbactam/ampicillin (50 and 100 mg/kg, respectively, qid) was evaluated in 21 patients with intracranial abscess(es). Sixteen patients had cerebral, 3 epidural, and 2 cerebellar abscesses. Multiple lesions were found in 7 patients. Sixteen patients underwent surgical intervention, others were treated with antibiotic alone. The mean duration of antibiotic therapy (+/- SD) was 48 +/- 10 days (range 26-65 days). The mean duration of follow-up after completion of therapy (+/- SD) was 6 +/- 2.4 months. All patients had at least some reduction in size of abscess(es) within 3 weeks of the initiation of therapy as monitored by computerized tomography. Seventeen patients were cured, three patients died due to causes unrelated to their infection. One patient was reoperated since no clear improvement either clinically or radiologically was observed 18 days after the first operation. Side effects of sulbactam/ampicillin were minor and transient. Results obtained in this study indicate that sulbactam/ampicillin can be used in the treatment of intracranial abscesses, alone or with surgical intervention.

    Topics: Adolescent; Adult; Ampicillin; Bacteroides Infections; Brain Abscess; Child; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prospective Studies; Staphylococcal Infections; Streptococcal Infections; Sulbactam

1993

Other Studies

3 other study(ies) available for sultamicillin and Brain-Abscess

ArticleYear
Detection of high serum levels of β-D-Glucan in disseminated nocardial infection: a case report.
    BMC infectious diseases, 2017, Apr-13, Volume: 17, Issue:1

    β-D-glucan (BDG) is a helpful diagnostic marker for many invasive fungal infections, but not for nocardiosis. Here, we reported the first case of nocardial infection with high serum level of BDG.. A 73-year-old man was hospitalized because of fever, headache, and appetite loss after 10 months of steroid and immunosuppressive therapy for cryptogenic organizing pneumonia. With a diagnosis of bacterial pneumonia, treatment with ampicillin/sulbactam was initiated. There was improvement on chest radiograph, but fever persisted. Further work-up revealed multiple brain abscesses on cranial magnetic resonance imaging (MRI). Serum galactomannan and BDG were elevated at 0.6 index and 94.7 pg/ml, respectively. Voriconazole was initiated for presumed aspergillus brain abscess. However, fever persisted and consciousness level deteriorated. Drainage of brain abscess was performed; based on the Gram stain and Kinyoun acid-fast stain, disseminated nocardiosis was diagnosed. Voriconazole was then shifter to trimethoprim/sulfamethoxazole. The presence of Nocardia farcinica was confirmed by the 16S rRNA gene sequence. Treatment course was continued; BDG level normalized after 1 month and cranial MRI showed almost complete improvement after 2 months.. BDG assay is widely used to diagnose invasive fungal infection; therefore, clinicians should be aware that Nocardia species may show cross-reactivity with BDG assay on serum.

    Topics: Aged; Ampicillin; Anti-Infective Agents; beta-Glucans; Brain Abscess; Drainage; Humans; Male; Nocardia Infections; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination

2017
[Brain abscess due to Fusobacterium necrophorum in a patient with convulsion and no signs of meningitis].
    Rinsho shinkeigaku = Clinical neurology, 2012, Volume: 52, Issue:6

    Here, we report brain abscess due to Fusobacterium necrophorum (F. necrophorum) in a 78-year-old healthy man. He developed convulsion and did not have any signs of meningitis. Although the brain magnetic resonance imaging findings of the left occipital lobe were typical of a brain abscess, his cerebrospinal fluid examination revealed only slight pleocytosis and mild increase in protein levels. Thus, it was difficult to rule out the possibility of metastatic brain tumor; the patient's condition was provisionally diagnosed as symptomatic epilepsy secondary to brain abscess. His convulsion disappeared soon after administration of antiepileptic, antibacterial, and steroid agents. A craniotomy was performed to evacuate the abscess, and F. necrophorum was identified by culturing the abscess contents. After the operation, he was treated with appropriate antibacterial agents, which resulted in resolution of the brain abscess. Although Fusobacterium species are gram-negative anaerobic bacilli commensal of the human oropharynx, we need to recognize that Fusobacterium species can be a primary pathogen causing brain abscesses and may leave residual neurological sequelae without early appropriate treatment.

    Topics: Aged; Ampicillin; Anti-Bacterial Agents; Brain Abscess; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Male; Meningitis, Bacterial; Seizures; Sulbactam; Therapeutics; Tomography, X-Ray Computed

2012
Pott puffy tumor complicating frontal sinusitis.
    The American journal of the medical sciences, 2010, Volume: 340, Issue:1

    Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Brain Abscess; Frontal Bone; Frontal Sinusitis; Humans; Magnetic Resonance Imaging; Male; Osteomyelitis; Sulbactam

2010